Adenosine A2A receptor and IL-10 in peripheral blood mononuclear cells of patients with mild cognitive impairment

7Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Adenosine suppresses immune responses through the A2A receptor (A2AR). This study investigated the interleukin 10 (IL-10) genetic profile and the expression of A2AR in peripheral blood mononuclear cells (PBMCs) of patients with mild cognitive impairment (MCI), Alzheimer disease (AD), and age-matched controls to verify, if they may help distinguish different forms of cognitive decline. We analyzed the IL-10 genotype and the expression of A2AR in 41 subjects with AD, 10 with amnestic MCI (a-MCI), 49 with multiple cognitive domain MCI (mcd-MCI), and 46 controls. There was a significant linear increase in A2AR mRNA levels and A 2AR density from mcd-MCI to a-MCI, with intermediate levels being found in AD. The IL-10 AA genotype frequency was 67 in a-MCI, 46 in AD, 35 in mcd-MCI, and 20 in controls. These data suggest that the assessment of the IL-10 genotype and the expression of A2AR in PBMCs may be a valuable means of differentiating between a-MCI and mcd-MCI. Copyright © 2011 Beatrice Arosio et al.

Cite

CITATION STYLE

APA

Arosio, B., Mastronardi, L., Gussago, C., Nicolini, P., Casè, A., Ziglioli, E., & Bergamaschini, L. (2011). Adenosine A2A receptor and IL-10 in peripheral blood mononuclear cells of patients with mild cognitive impairment. International Journal of Alzheimer’s Disease. https://doi.org/10.4061/2011/484021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free